Physicians Using Newest CoolSculpting Applicator to Sculpt Inner Thighs
ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the 11th Anti-Aging Medicine World Congress (AMWC) in Monaco, April 4-6, 2013, and will highlight CoolFit, the newest addition to the applicator platform for the CoolSculpting System. CoolFit's advanced engineering design features a flat applicator cup and 38 percent larger cooling plates (than the CoolCore applicator), allowing physicians to treat longer and hard-to-reach fat bulges such as the inner thigh. CoolSculpting is a non-surgical, clinically proven procedure that selectively reduces fat in problem areas using a patented cooling technology.
Dr. Tracy Mountford, founder and medical director of The Cosmetic Skin Clinic in London, will be speaking about CoolFit during her session, "Multi-Center Evaluation of a Flat Cryolipolysis Applicator for Non-Surgical Contouring of the Inner Thigh." The session takes place on Thursday, April 4, 2-4 p.m., in the Room Van Dongen on Level 2.
| WHAT: | CoolFit Applicator | |||||
| ZELTIQ Aesthetics, Booth #01, Hall Ravel, Level 1 | ||||||
| WHEN: | Thursday, April 4, 2013, 13:00 19:00 | |||||
| Friday, April 5, 2013, 8:00 19:00 | ||||||
| Saturday, April 6, 2019, 8:00 17:00 | ||||||
| WHERE: | Anti-Aging Medicine World Congress (AMWC) Annual Conference | |||||
| Le Grimaldi Forum | ||||||
| 10 avenue Princesse Grace 9800 | ||||||
| Monte Carlo | ||||||
About ZELTIQ Aesthetics, Inc.
ZELTIQis a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
CoolSculpting System is CE marked for general non-invasive fat reduction. In the United States and Taiwan CoolSculpting is cleared for non-invasive fat reduction of the abdomen and flank. Media alert not intended for distribution in the United States.
Contacts:
Nat'Communication for ZELTIQ
Nathalie d'Amico
+ 33 6 08 57 82 11
nathalie@natcommunication.fr
